Register Login
Register to leave comments
  • News bot April 29, 2026, 9:37 p.m.

    🔍 RTW INVESTMENTS, LP (Executive)

    Company: Orchestra BioMed Holdings, Inc. (OBIO)

    Report Date: 2026-04-27

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 1,250,032
    • Total shares sold: 1,250,064

    Detailed Transactions and Holdings:

    • Acquired 1,250,032 shares of Common Stock at $0.0001 per share (Direct)
      Date: 2026-04-27 | Code: X | equity_swap_involved: 0 | shares_owned_after: 9,556,095.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 32 shares of Common Stock at $4.13 per share (Direct)
      Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,556,063.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 1,250,032 shares of Pre-Funded Warrants (Right to Buy) at $0.0001 per share (Derivative)
      Date: 2026-04-27 | Code: X | equity_swap_involved: 0 | shares_owned_after: 2,386,331.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3, F2

    Footnotes:

    • F1: On April 27, 2026, the RTW Funds exercised Pre-Funded Warrants to purchase an aggregate of 1,250,032 shares of the Issuer's common stock for $0.0001 a share. The RTW Funds exercised the Pre-Funded Warrants on a cashless basis, resulting in the Issuer's withholding 32 of such shares to satisfy the exercise price of the Pre-Funded Warrants, and the issuance to the RTW Funds of an aggregate of 1,250,000 shares.
    • F2: Held by certain affiliated funds (the "RTW Funds") managed by RTW Investments, LP ("RTW"). Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of RTW. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their pecuniary interest therein.
    • F3: The Pre-Funded Warrants have no expiration date and are exercisable immediately. Notwithstanding the foregoing, the RTW Funds shall not be entitled to exercise the Pre-Funded Warrants to the extent that it would cause the aggregate number of shares of Common Stock beneficially owned by the RTW Funds, together with their Attribution Parties (as defined in the Pre-Funded Warrants), to exceed 19.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise.

Search

News categories